What You Should Know:
- Cerner announces it will acquire Kantar Health, a leading data, analytics, and real-world evidence and commercial research consultancy serving the life science and health care industry.
- This acquisition is expected to allow Cerner’s Learning
Health Network client consortium and health systems with more opportunities to
directly engage with life sciences for funded research studies. The acquisition
is expected to close during the first half of
Read More
Oncology Technology Solutions, Services Impacting Patients and Providers
Mount Sinai to Deploy Current Health’s RPM Solution to Enhance Oncology Patient Care
What You Should Know:
- Mount Sinai Health System will implement Current Health’s
remote patient monitoring (RPM) solution to allow oncology patients to recover
at home while being continuously and passively monitored by their care team.
- The implementation will reduce hospitalization events and prevent potential patient exposure to infection while bridging the digital health divide as more and more patients engage in telehealth.
Current Health
today announced that its remote patient
Read More
COTA Lands $34M to Drive Innovation in Oncology Using Real-World Data
What You Should Know:
- COTA, Inc., a healthcare technology company that uses
real-world data to bring clarity to cancer care, has secured $34M in funding.
- Access to over one million patient data records and additional
funding support enhanced real-world data and analytics services in oncology.
COTA, Inc., a Boston, MA-based healthcare technology company that uses real-world data to bring clarity to cancer care, today announced it has raised $34 million in Series D funding led by
Read More
M&A: RxVantage Acquires onPoint Oncology to Expand Offering to Oncology Practices
What You Should Know:
- RxVantage has acquired onPoint Oncology to provide cancer care teams with on-demand access to educational resources, reimbursement data, and analytics.
- The acquisition of onPoint Oncology builds on
RxVantage’s rapidly expanding digital offerings for providers. In April,
RxVantage launched Virtual Meetings to help providers reestablish access to
life science experts amidst the disruptions caused by COVID-19.
RxVantage, the
leading digital
Read More
FDA Extends RCA With COTA to Explore COVID’s Effect on Cancer
What You Should Know:
- The FDA just extended its research collaboration
agreement (RCA) with COTA, specifically looking at how COVID-19 is affecting
cancer.
- With this expanded agreement, COTA and the FDA will use real-world data to explore the impact of COVID-19 and the pandemic on cancer treatment, with the opportunity to expand into other oncology questions in the future.
COTA, Inc., a healthcare technology
company that uses real-world data to bring clarity to cancer care,
Read More
Redox Integrates Voluntis’ Digital Therapeutics Within EHR
What You Should Know:
- Voluntis forms a strategic partnership with Redox to integrate Voluntis' digital therapeutics within existing clinical workflows and EHRs.
- Integration of Voluntis’ Theraxium platform with the
Redox Engine used by more than 900 healthcare organizations using 55 EHRs
across the country.
- The first area of this application will be in oncology,
with future extensions in other therapeutic areas. As a result, clinical staff
will be better equipped to serve each
Read More
Northwestern to Deploy FDA-Cleared Deploy AI-Guided Cardiac Ultrasounds
What You Should Know:
- Northwestern Memorial Hospital is the first in the
nation to deploy FDA-cleared AI-guided ultrasound by Caption Health, including
measurement of ejection fraction – the most widely used measurement to assess
cardiac function.
- Caption Health's AI-guided cardiac ultrasound enables clinicians – including those without experience – to accurately perform diagnostic-quality exams -- accelerating the availability of information and saving lives.
- Caption AI has been
Read More
Impact of COVID-19: 2020 State of Healthcare Performance Improvement Report
What You Should Know:
- Nearly three-quarters of hospital leaders are either
moderately (52%) or extremely (22%) concerned about the financial viability of
their organizations without an effective treatment or vaccine for COVID-19,
according to a new report from Kaufman Hall entitled, “2020 State of Healthcare
Performance Improvement Report: The Impact of COVID-19”
- One-third of respondents saw operating margin declines
in excess of 100% in the second quarter of 2020 compared with the
Read More
Thriving in a Value-Based Care Environment: Impacting Outcome-to-Cost Ratio
As the COVID-19 pandemic creates surges in acute care, many imaging departments are experiencing a decrease in volume, due to patients deferring or canceling non-urgent appointments and surgeries. The impact of this makes it painfully obvious that -- because imaging departments rely on a fee-for-service model – when the volume is down, finances suffer. As an aspect of healthcare that has historically been hyper-focused on volume, adoption of a value-based care approach in radiology has evolved
Read More
Syapse Appoints David Pomerantz as Chief Commercial Officer
Syapse, a real-world evidence company accelerating the delivery of precision medicine through the Syapse Learning Health Network™, today announced the appointment of David Pomerantz as Chief Commercial Officer. In his new role as Chief Commercial Officer, Pomerantz will lead the future direction of Syapse’s commercial endeavors and expand its life sciences partnerships across the Syapse Learning Network.
Pomerantz Bio/Background
Mr. Pomerantz brings more than 25 years of account
Read More
